WORCESTER, Mass., Aug. 24, 2009 (GLOBE NEWSWIRE) -- Anna E. Gluskin, the chairman, president and CEO of Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), was featured this morning on "Market News" on Canada's Business News Network (BNN) to discuss the current circumstances of H1N1 and how Generex's synthetic vaccine platform can respond to the swine flu's ever-changing DNA. The segment can be viewed online at http://watch.bnn.ca/clip206593#clip206594 and will be available later today at www.generex.com.
